Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Selected Financial Data
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Income Statement

Medtronic PLC, selected items from income statement, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).

Net Sales
Net sales exhibited a consistent upward trend over the examined period, increasing steadily from 10,055 million USD in 2005 to 32,364 million USD in 2024. Notably, there was a significant increase from 20,261 million USD in 2015 to 28,833 million USD in 2016. Following this, sales continued to rise but at a relatively slower pace, with minor fluctuations such as a decrease observed in 2020 (28,913 million USD) compared to 2019 (30,557 million USD), likely reflecting external impacts during that year. After 2020, sales resumed growth, reaching a new peak in 2024.
Operating Profit
Operating profit data is available only starting from 2012. In that year, the company reported 4,402 million USD, which decreased slightly over the next couple of years to 3,766 million USD in 2014. Subsequently, there was a marked increase, peaking at 6,268 million USD in 2017. After this peak, operating profit declined notably over the next two years, reaching 4,484 million USD in 2019. The trend reversed again, with operating profit gradually recovering to 5,752 million USD in 2021, before slightly declining over the subsequent years up to 2024. These fluctuations may suggest varying operational efficiencies or cost structures across the years.
Net Income Attributable to Medtronic
Net income showed variability throughout the entire period. Beginning at 1,804 million USD in 2005, it rose steadily to a high of 4,631 million USD in 2018, despite some intermittent declines, such as in 2008 and 2014. After reaching this peak, net income decreased to 3,606 million USD in 2021 but then increased again to 5,039 million USD in 2022, representing the highest value in the series. Following this peak, the net income declined to 3,676 million USD in 2024. These fluctuations suggest periods of variable profitability potentially influenced by operational factors, market conditions, and extraordinary items.
Overall Insights
The company's revenue base has expanded substantially over the two decades, reflecting growth in market reach or product demand. Operating profit data suggests periods of both significant operational gains and challenges, possibly tied to investments, restructuring, or market dynamics. Net income shows a more volatile pattern, indicating the impact of non-operational items, tax considerations, or fluctuating expense levels. The trends collectively point to a general growth trajectory with intermittent periods of financial pressure or restructuring.

Balance Sheet: Assets

Medtronic PLC, selected items from assets, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).

The analysis of the financial data reveals several notable trends in the company's asset composition over the examined periods.

Current Assets
The current assets show a generally increasing trend from 2005 through 2015, growing from approximately 7,422 million US dollars in April 2005 to a peak of around 30,844 million US dollars in April 2015. This indicates a significant buildup in the company’s short-term resources during this decade. After this peak, current assets decline noticeably in the subsequent years, falling to about 23,600 million US dollars in April 2016, followed by smaller fluctuations between approximately 21,675 and 23,059 million US dollars from 2013 to 2024. This suggests a retraction and stabilization of current assets at a lower level than the peak observed in 2015.
Total Assets
Total assets also trend upward initially, rising steadily from approximately 16,617 million US dollars in April 2005 to a substantial peak of about 106,685 million US dollars in April 2015. This peak aligns with the highest current assets level, indicating overall expansion of the company's asset base. Following this peak, total assets experience a moderate decrease and some volatility, stabilizing around the 90,000 million US dollars mark from 2016 onward, with gradual declines and minor fluctuations through the most recent date in April 2024. This behavior suggests possible divestitures, asset revaluation, or a strategic shift in asset management after the 2015 high.

Overall, the data demonstrate a period of considerable growth in both current and total assets up to 2015, followed by a contraction and stabilization phase through to 2024. The sharp increase until 2015 may reflect expansion or acquisitions, while the subsequent reduction could indicate optimization efforts or changes in operational structure. The stabilization in recent years suggests the company reached a new equilibrium in asset structure.


Balance Sheet: Liabilities and Stockholders’ Equity

Medtronic PLC, selected items from liabilities and stockholders’ equity, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).

The analysis of the annual financial data reveals several notable trends in liabilities, debt, and shareholders' equity over the observed period.

Current Liabilities
Current liabilities exhibit significant fluctuations across the years. Initially, there was an increase from approximately 3,380 million US dollars in 2005 to a peak of 5,873 million in 2012. This was followed by pronounced volatility, including sharp spikes, notably in 2015 where the value nearly doubled from the previous year. More recent years show a pattern of increases and decreases, ending with a moderate rise in 2024 compared to 2023. Overall, the trend lacks steady growth or decline, indicating potential variability in short-term obligations or operating conditions.
Total Liabilities
Total liabilities show a general increasing trend from 6,168 million US dollars in 2005 to a substantial peak of 53,455 million in 2015. This significant jump reflects either acquisition of debt, recognition of larger obligations, or other liability increases. Post-2015, total liabilities decline sharply and stabilize within a range between approximately 38,000 and 49,000 million US dollars. The reduction after 2015 suggests substantial deleveraging or restructuring of the company's obligations.
Total Debt
Total debt closely follows the pattern observed in total liabilities, rising from 2,452 million in 2005 up to 36,186 million in 2015, consistent with the peak in total liabilities. After 2015, total debt declines significantly and then exhibits smaller fluctuations while remaining within the 24,000 to 33,000 million range. The debt peak and subsequent decrease mirror shifts in financial strategy, possibly indicating repayment or refinancing activities.
Shareholders’ Equity
Shareholders’ equity shows a generally upward trend in the early years, increasing from 10,450 million in 2005 to approximately 19,443 million by 2014. There is a dramatic rise to 53,230 million in 2015, aligning with the surge in liabilities and debt, which may point to a one-time event such as an equity issuance or accounting reclassification impacting the equity base. After this spike, equity stabilizes around the 50,000 to 52,000 million range with minor fluctuations, slightly declining to about 50,214 million by 2024. This pattern suggests a period of growth followed by stabilization in the company’s net worth.

In summary, the financial data reveals a significant change event around 2015, marked by sharp increases in liabilities, debt, and equity. Before 2015, the company experienced gradual growth in equity and fluctuating but generally rising debt and liabilities. After 2015, liabilities and debt decreased considerably and stabilized, while equity also leveled off. Current liabilities remain more volatile, indicating ongoing short-term financial management challenges. These patterns highlight a transition period in the mid-2010s, with potential strategic or structural financial adjustments affecting the overall financial position.


Cash Flow Statement

Medtronic PLC, selected items from cash flow statement, long-term trends

US$ in millions

Microsoft Excel

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).

Net Cash Provided by Operating Activities
The net cash from operating activities exhibits an overall positive trend, starting at 2,819 million USD in 2005 and fluctuating with periodic increases and decreases over the years. Notable peaks appear in 2015 (6,880 million USD), 2019 (7,007 million USD), and 2021 (7,234 million USD). Despite some volatility, the operating cash flow remains substantial, indicating generally strong operational cash generation capacity throughout the period. A dip is observed in 2018 to 4,684 million USD, which is followed by a recovery in subsequent years. The most recent year shows a moderate level of 6,787 million USD, suggesting maintained operational effectiveness.
Net Cash Used in Investing Activities
The net cash used in investing activities displays considerable variability and predominantly negative values, indicating consistent cash outflows related to investments. Early years show significant outflows, with a high of -4,759 million USD in 2010. A major exception occurs in 2015 with a substantial positive inflow of 2,245 million USD, followed by another positive spike in 2018 at 5,858 million USD, reflecting possible divestitures or asset sales. These positive inflows are surrounded by periods of heavy investment outflows, reaching -17,058 million USD in 2014, indicative of aggressive investment activity during that year. Overall, investing cash flow results suggest a pattern of cyclical asset acquisition and occasional asset sales or returns.
Net Cash Provided by (Used in) Financing Activities
Financing activities demonstrate a fluctuating pattern with alternating inflows and outflows. From 2005 to 2014, the company shows a mix of small inflows and significant outflows, including a highly negative cash flow of -3,011 million USD in 2007 and another severe negative outflow of -9,543 million USD in 2015. The year 2014 stands out with a large inflow of 15,949 million USD, likely linked to capital raising or debt issuance. Following 2015, financing cash flows trend consistently negative, with outflows ranging from approximately -4,000 to -5,300 million USD, indicating ongoing debt repayments, share buybacks, or dividend payments. This overall pattern points to active management of capital structure with periods of capital injection and sustained repayments or distributions in recent years.

Per Share Data

Medtronic PLC, selected data per share, long-term trends

US$

Microsoft Excel

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).

1, 2, 3 Data adjusted for splits and stock dividends.

The financial data reveals distinct patterns in the earnings per share (EPS) and dividends per share over a 20-year period. Both basic and diluted earnings per share show fluctuating trends with periods of growth and decline, while dividends per share exhibit a steady and consistent increase.

Basic Earnings per Share (EPS)
The basic EPS increased from $1.49 in 2005 to a peak of $3.75 in 2022, demonstrating overall growth across the period. However, this growth was not linear; notable dips occurred, such as in 2008 when EPS fell to $1.97 from $2.44 in 2007, and again in 2018, declining from $2.92 in 2017 to $2.29. Sharp recoveries followed these declines, with the EPS rising to $3.44 in 2019 and then fluctuating again until 2024, where it settled at $2.77. This pattern suggests the company experienced cyclical challenges or one-time events impacting profitability but maintained the capacity for recovery.
Diluted Earnings per Share
The diluted EPS mirrors the basic EPS closely, indicating minimal differential impact from potential share dilution. Trends in diluted EPS also reflect cyclical fluctuations, peaking at $3.73 in 2022 and exhibiting similar declines and recoveries observed in the basic EPS. The parallel movement underscores consistent earnings quality and stable dilution factors over time.
Dividend per Share
Dividend per share demonstrates a steady upward trajectory without interruptions or reversals, increasing from $0.34 in 2005 to $2.76 in 2024. This consistent rise indicates a strong focus on shareholder returns, suggesting confidence in the company’s cash flow and commitment to rewarding investors regardless of earnings volatility.

Overall, the data indicates that, while earnings experienced variability, the company maintained a progressive dividend policy. The pattern of recovering earnings alongside rising dividends may reflect effective management strategies to balance reinvestment and shareholder remuneration despite fluctuating profitability levels.